New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.

Peptistar has integrated Asahi Kasei’s novel forward osmosis–membrane distillation (FO–MD) system into its facility for trial production of APIs.

Tanzania national team captain Mbwana Samatta has officially announced his retirement from international football, concluding ...

Welcome to our rolling coverage of the 2026 Airport Food & Beverage (FAB) + Hospitality Conference and Awards, held this year ...

Warner Bros. reveals a first look at a new animated fantasy movie, Prehistoria, from Vivienne Medrano, the creator of Prime ...

Anthropic, the AI company behind the Claude family of models, confidentially submitted a draft S-1 registration statement ...

Key Points Interested in Micron Technology, Inc.? Here are five stocks we like better. A $137 billion memory-stock sell-off ...

Japanese pharmaceutical contract development and manufacturing organization (CDMO) Peptistar has integrated Asahi Kasei Corp.

The Roanoke City Council voted 4-3 on Monday night to delay a highly anticipated decision on rolling back its 2024 ...

In this white paper, we will discuss the emerging trend in which hardware is increasingly designed to meet the end functionality of today’s systems, which is largely defined in software. This emerging ...

Over the past several decades, the semiconductor industry has experienced sustained growth. Early expansion was driven by the ...

EXCLUSIVE: The Transgender Film Center has revealed its latest group of fellows for the 2025-26 Career Development Lab. These 10 film and television artists, who are now set to graduate from the ...